(Axios) – A review of rules governing Colorado’s psychedelic therapy program will include potentially expanding the substances available for treatment. Why it matters: The change would make Colorado the first state to use ibogaine — a psychoactive found in the … Read More
https://bioethics.com/archives/101436
